By downregulating the PI3K/AKT-mediated SREBP1/FASN pathway, bufalin effectively suppresses de novo fatty acid synthesis, which is critical for CRC progression and liver metastasis. The gene discussed is AKT1; the disease is colorectal carcinoma.